Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for AMFPF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2002. Start Trial.
Date Value
March 31, 2026 4.525B
December 31, 2025 4.572B
September 30, 2025 4.511B
June 30, 2025 4.534B
March 31, 2025 4.284B
December 31, 2024 4.135B
September 30, 2024 4.339B
June 30, 2024 4.123B
March 31, 2024 4.160B
December 31, 2023 4.080B
September 30, 2023 3.873B
June 30, 2023 3.942B
March 31, 2023 3.874B
December 31, 2022 3.816B
September 30, 2022 3.511B
June 30, 2022 3.710B
March 31, 2022 3.989B
December 31, 2021 3.998B
September 30, 2021 3.853B
June 30, 2021 3.869B
March 31, 2021 3.891B
December 31, 2020 3.950B
September 30, 2020 3.606B
June 30, 2020 3.454B
March 31, 2020 3.235B
Date Value
December 31, 2019 3.201B
September 30, 2019 3.086B
June 30, 2019 3.189B
March 31, 2019 3.073B
December 31, 2018 2.536B
September 30, 2018 1.833B
June 30, 2018 1.940B
March 31, 2018 1.858B
December 31, 2017 1.760B
September 30, 2017 1.674B
June 30, 2017 1.629B
March 31, 2017 1.545B
December 31, 2016 1.483B
September 30, 2016 1.493B
June 30, 2016 1.441B
March 31, 2016 1.451B
December 31, 2015 1.398B
September 30, 2015 1.347B
June 30, 2015 1.393B
March 31, 2015 1.420B
December 31, 2014 1.517B
September 30, 2014 1.500B
June 30, 2014 1.627B
March 31, 2014 1.582B
December 31, 2013 1.566B

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Interpace Biosciences, Inc. 33.41M
Medical Marijuana, Inc. 66.31M
DiaSorin SpA --
Akso Health Group --
Acro Biomedical Co. Ltd. 0.0039M

Total Assets (Quarterly) Related Metrics